FDA Inspection 863455 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3007320762

The FDA completed an inspection of Octapharma Plasma, Inc. on Jan 17, 2014 in Spokane, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 17, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Spokane, WA (United States)